Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial.


Autoria(s): Attard, Gerhardt; Sydes, Matthew R; Mason, Malcolm D; Clarke, Noel W; Aebersold, Daniel; de Bono, Johann S; Dearnaley, David P; Parker, Chris C; Ritchie, Alastair W S; Russell, J Martin; Thalmann, George; Cassoly, Estelle; Millman, Robin; Matheson, David; Schiavone, Francesca; Spears, Melissa R; Parmar, Mahesh K B; James, Nicholas D
Data(s)

27/06/2014

Resumo

There are compelling reasons to study the addition of both enzalutamide and abiraterone, in combination, to standard-of-care for hormone-naïve prostate cancer. Through a protocol amendment, this will be assessed in the STAMPEDE trial, with overall survival as primary outcome measure.

Formato

application/pdf

Identificador

http://boris.unibe.ch/61607/1/1-s2.0-S030228381400520X-main.pdf

Attard, Gerhardt; Sydes, Matthew R; Mason, Malcolm D; Clarke, Noel W; Aebersold, Daniel; de Bono, Johann S; Dearnaley, David P; Parker, Chris C; Ritchie, Alastair W S; Russell, J Martin; Thalmann, George; Cassoly, Estelle; Millman, Robin; Matheson, David; Schiavone, Francesca; Spears, Melissa R; Parmar, Mahesh K B; James, Nicholas D (2014). Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial. European urology, 66(5), pp. 799-802. Elsevier 10.1016/j.eururo.2014.05.038 <http://dx.doi.org/10.1016/j.eururo.2014.05.038>

doi:10.7892/boris.61607

info:doi:10.1016/j.eururo.2014.05.038

info:pmid:24985962

urn:issn:0302-2838

Idioma(s)

eng

Publicador

Elsevier

Relação

http://boris.unibe.ch/61607/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Attard, Gerhardt; Sydes, Matthew R; Mason, Malcolm D; Clarke, Noel W; Aebersold, Daniel; de Bono, Johann S; Dearnaley, David P; Parker, Chris C; Ritchie, Alastair W S; Russell, J Martin; Thalmann, George; Cassoly, Estelle; Millman, Robin; Matheson, David; Schiavone, Francesca; Spears, Melissa R; Parmar, Mahesh K B; James, Nicholas D (2014). Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial. European urology, 66(5), pp. 799-802. Elsevier 10.1016/j.eururo.2014.05.038 <http://dx.doi.org/10.1016/j.eururo.2014.05.038>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed